213 related articles for article (PubMed ID: 30185079)
1. Chaperone-mediated autophagy as a therapeutic target for Parkinson disease.
Campbell P; Morris H; Schapira A
Expert Opin Ther Targets; 2018 Oct; 22(10):823-832. PubMed ID: 30185079
[TBL] [Abstract][Full Text] [Related]
2. Essential control of mitochondrial morphology and function by chaperone-mediated autophagy through degradation of PARK7.
Wang B; Cai Z; Tao K; Zeng W; Lu F; Yang R; Feng D; Gao G; Yang Q
Autophagy; 2016 Aug; 12(8):1215-28. PubMed ID: 27171370
[TBL] [Abstract][Full Text] [Related]
3. Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA).
Ho PW; Leung CT; Liu H; Pang SY; Lam CS; Xian J; Li L; Kung MH; Ramsden DB; Ho SL
Autophagy; 2020 Feb; 16(2):347-370. PubMed ID: 30983487
[TBL] [Abstract][Full Text] [Related]
4. Chaperone-mediated autophagy controls the turnover of E3 ubiquitin ligase MARCHF5 and regulates mitochondrial dynamics.
Nie T; Tao K; Zhu L; Huang L; Hu S; Yang R; Xu P; Mao Z; Yang Q
Autophagy; 2021 Oct; 17(10):2923-2938. PubMed ID: 33970775
[TBL] [Abstract][Full Text] [Related]
5. Chaperone-mediated autophagy in neurodegenerative diseases: mechanisms and therapy.
Liu Y; Tan L; Tan MS
Mol Cell Biochem; 2023 Oct; 478(10):2173-2190. PubMed ID: 36695937
[TBL] [Abstract][Full Text] [Related]
6. Chaperone mediated autophagy to the rescue: A new-fangled target for the treatment of neurodegenerative diseases.
Xilouri M; Stefanis L
Mol Cell Neurosci; 2015 May; 66(Pt A):29-36. PubMed ID: 25724482
[TBL] [Abstract][Full Text] [Related]
7. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
[TBL] [Abstract][Full Text] [Related]
8. Glucocerebrosidase deficits in sporadic Parkinson disease.
Murphy KE; Halliday GM
Autophagy; 2014 Jul; 10(7):1350-1. PubMed ID: 24915553
[TBL] [Abstract][Full Text] [Related]
9. Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy.
Xilouri M; Vogiatzi T; Vekrellis K; Park D; Stefanis L
PLoS One; 2009; 4(5):e5515. PubMed ID: 19436756
[TBL] [Abstract][Full Text] [Related]
10. Chaperone-Mediated Autophagy and Its Emerging Role in Hematological Malignancies.
Robert G; Jacquel A; Auberger P
Cells; 2019 Oct; 8(10):. PubMed ID: 31623164
[TBL] [Abstract][Full Text] [Related]
11. Impairment of chaperone-mediated autophagy induces dopaminergic neurodegeneration in rats.
Xilouri M; Brekk OR; Polissidis A; Chrysanthou-Piterou M; Kloukina I; Stefanis L
Autophagy; 2016 Nov; 12(11):2230-2247. PubMed ID: 27541985
[TBL] [Abstract][Full Text] [Related]
12. Th17 cells: a promising therapeutic target for Parkinson's disease?
Prots I; Winner B
Expert Opin Ther Targets; 2019 Apr; 23(4):309-314. PubMed ID: 30871383
[TBL] [Abstract][Full Text] [Related]
13. Chaperone-mediated autophagy: Advances from bench to bedside.
Li W; Nie T; Xu H; Yang J; Yang Q; Mao Z
Neurobiol Dis; 2019 Feb; 122():41-48. PubMed ID: 29800676
[TBL] [Abstract][Full Text] [Related]
14. Autophagic pathways in Parkinson disease and related disorders.
Xilouri M; Stefanis L
Expert Rev Mol Med; 2011 Mar; 13():e8. PubMed ID: 21418705
[TBL] [Abstract][Full Text] [Related]
15. Chaperone mediated autophagy in aging: Starve to prosper.
Xilouri M; Stefanis L
Ageing Res Rev; 2016 Dec; 32():13-21. PubMed ID: 27484893
[TBL] [Abstract][Full Text] [Related]
16. A new perspective in Parkinson's disease, chaperone-mediated autophagy.
Li B; Zhang Y; Yuan Y; Chen N
Parkinsonism Relat Disord; 2011 May; 17(4):231-5. PubMed ID: 21215675
[TBL] [Abstract][Full Text] [Related]
17. 6-OHDA Induces Oxidation of F-box Protein Fbw7β by Chaperone-Mediated Autophagy in Parkinson's Model.
Wang X; Zhai H; Wang F
Mol Neurobiol; 2018 Jun; 55(6):4825-4833. PubMed ID: 28733899
[TBL] [Abstract][Full Text] [Related]
18. Dysfunction of chaperone-mediated autophagy in human diseases.
Liao Z; Wang B; Liu W; Xu Q; Hou L; Song J; Guo Q; Li N
Mol Cell Biochem; 2021 Mar; 476(3):1439-1454. PubMed ID: 33389491
[TBL] [Abstract][Full Text] [Related]
19. Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy.
Martinez-Vicente M; Talloczy Z; Kaushik S; Massey AC; Mazzulli J; Mosharov EV; Hodara R; Fredenburg R; Wu DC; Follenzi A; Dauer W; Przedborski S; Ischiropoulos H; Lansbury PT; Sulzer D; Cuervo AM
J Clin Invest; 2008 Feb; 118(2):777-88. PubMed ID: 18172548
[TBL] [Abstract][Full Text] [Related]
20. Valeric Acid Protects Dopaminergic Neurons by Suppressing Oxidative Stress, Neuroinflammation and Modulating Autophagy Pathways.
Jayaraj RL; Beiram R; Azimullah S; Mf NM; Ojha SK; Adem A; Jalal FY
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
